Epcoritamab (EPCOR) monotherapy demonstrates deep and durable responses at 3-year follow-up (FU) in patients (PTS) with relapsed/refractory (R/R) follicular lymphoma (FL)


Por: Scholz, C, Vitolo, U, Jurczak, W, Lugtenburg, PJ, Gyan, E, Chavez, JC, Sureda, A, Christensen, JH, Tilly, H, Cordoba, R, Lewis, DJ, Hutchings, M, Clausen, MR, Sancho, JH, Cochrane, T, Leppä, S, Chamuleau, MED, Thieblemont, C, Izutsu, K, Fukuhara, N, Caimi, PF, Karimi, YH, Andreadis, C, Vose, JM, Favaro, E, Patah, P, Geybels, M, Altintas, I, Morehouse, C and Linton, KM

Publicada: 20 oct 2025
Resumen:


Filiaciones:
Scholz, C:
 Vivantes Klinikum Urban, Dept Hematol & Oncol, Berlin, Germany

Vitolo, U:
 FPO IRCCS, Candiolo Canc Inst, Turin, Italy

Jurczak, W:
 Maria Sklodowska Curie Natl Res Inst Oncol, Krakow, Poland

Lugtenburg, PJ:
 Univ Med Ctr, Erasmus MC Canc Inst, Lunenburg Lymphoma Phase Consortium HOVON LLPC 1 2, Rotterdam, Netherlands

Gyan, E:
 Ctr Hosp Univ Tours, Serv Hematol & Therapie Cellulaire, CIC INSERM U1415, Tours, France

Chavez, JC:
 H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

Sureda, A:
 IDIBELL, Inst Catala Oncol Lhospitalet, Barcelona, Spain

 Univ Barcelona, Barcelona, Spain

Christensen, JH:
 Odense Univ Hosp, Odense, Denmark

Tilly, H:
 Univ Rouen, Ctr Henri Becquerel, Rouen, France

Cordoba, R:
 Fdn Jimenez Diaz Univ Hosp, Madrid, Spain

Lewis, DJ:
 Univ Hosp Plymouth NHS Trust, Derriford Hosp, Plymouth, England

Hutchings, M:
 Rigshospitalet, Copenhagen, Denmark

 Univ Copenhagen, Copenhagen, Denmark

Clausen, MR:
 Vejle Hosp, Vejle, Denmark

:
 ICO Hosp Germans Trias & Pujol, Catalan Inst Oncol ICO, Barcelona, Spain

Cochrane, T:
 Gold Coast Univ Hosp, Gold Coast, Australia

Leppä, S:
 Univ Helsinki, Helsinki, Finland

 Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland

Chamuleau, MED:
 Vrije Univ Amsterdam Med Ctr, Lunenburg Lymphoma Phase Consortium HOVON LLPC 1 2, Amsterdam UMC, Amsterdam, Netherlands

Thieblemont, C:
 Univ Paris, Hop St Louis, Assistance Publ Hop Paris, Hematooncol, Paris, France

Izutsu, K:
 Natl Canc Ctr, Tokyo, Japan

Fukuhara, N:
 Tohoku Univ Hosp, Sendai, Japan

Caimi, PF:
 Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

Karimi, YH:
 Univ Michigan, Ann Arbor, MI USA

Andreadis, C:
 Univ Calif San Francisco, San Francisco, CA USA

Vose, JM:
 Univ Nebraska Med Ctr, Omaha, NE USA

Favaro, E:
 Genmab, Plainsboro, NJ USA

Patah, P:
 AbbVie, N Chicago, IL USA

Geybels, M:
 Genmab, Copenhagen, Denmark

Altintas, I:
 Genmab, Utrecht, Netherlands

Morehouse, C:
 Genmab, Plainsboro, NJ USA

Linton, KM:
 Univ Manchester, Christie NHS Fdn Trust, Manchester Canc Res Ctr, Manchester, England

 Univ Manchester, Div Canc Sci, Manchester, England
ISSN: 22965262





Oncology Research and Treatment
Editorial
S. Karger AG, ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, Suiza
Tipo de documento: Meeting Abstract
Volumen: 48 Número: SUPPL 2
Páginas:
WOS Id: 001639100700826

MÉTRICAS